Skip to content
Screener

Marvell Technology, Inc. MRVL Restructuring and Asset Impairment Charges

Restructuring and Asset Impairment Charges at other companies

Howmet Aerospace logo
Howmet AerospaceHWM
-$93M-2,225%
Ciena logo
CienaCIEN
$1.5M-3.0%
Xylem logo
XylemXYL
$31M+47.6%
Smurfit Kappa Group logo
Smurfit Kappa GroupSW
$54M+260%
Staar Surgical logo
Staar SurgicalSTAA
$2.68M-88.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%

Segments

By segment

See full
Reportable Segment$8.7M+171%

Other financials

Income statement

See full
Revenue$2.4B+27.6%
Gross profit$1.3B+32.4%
Operating income$339.4M+25.4%
Net income$34.5M-80.6%
EPS (diluted)$0.04-80.0%

Balance sheet

See full
Cash & equivalents$3.8B+334%
Total debt$5.3B+17.0%
Total equity$18.2B+36.8%
Total assets$26.9B+34.6%

Cash flow

See full
Operating cash flow$638.8M+91.9%
CapEx$155.7M+31.1%
Free cash flow$483.1M+126%

Valuation

See full
Market cap$189.4B+192%
Enterprise value$190.83B+179%
P/E75×—
P/S21.7×+12.8×

Profitability

See full
Gross margin51.5%+8.3pp
Operating margin16%—
Net margin29%—
FCF margin19.1%-2.1pp

Returns & leverage

See full
Return on equity16%—
Debt / equity0.3×0.0×
Current ratio3.3×+2.0×